High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan.
Narimatsu
H
H
Watanabe
M
M
Kohno
A
A
Sugimoto
K
K
Kuwatsuka
Y
Y
Uchida
T
T
Murata
M
M
Miyamura
K
K
Morishita
Y
Y
D036101:Cord Blood Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D005260:Female; D006085:Graft Survival; D006801:Humans; D008297:Male; D008558:Melphalan / Q000009:adverse effects*; D008875:Middle Aged; D019653:Myeloablative Agonists / Q000009:adverse effects*; D010865:Pilot Projects; D019172:Transplantation Conditioning / Q000009:adverse effects* / Q000379:methods; D017211:Treatment Failure; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
D019653:Myeloablative Agonists; D014740:Vidarabine; C024352:fludarabine; D008558:Melphalan